Duration of First Off-Treatment Interval Is Prognostic for Time to Castration Resistance and Death in Men With Biochemical Relapse of Prostate Cancer Treated on a Prospective Trial...

Por Yu, Evan Y., Gulati, Roman, Telesca, Donatello, Jiang, Peter, Tam, Stephen, Russell, Kenneth J., Nelson, Peter S., Etzioni, Ruth D., Higano, Celestia S.
Publicado em 2010

External beam radiotherapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens

Por Cho, Eunpi, Mostaghel, Elahe A., Russell, Kenneth J., Liao, Jay J., Konodi, Mark A., Kurland, Brenda F., Marck, Brett T., Matsumoto, Alvin M., Dalkin, Bruce L., Montgomery, R. Bruce
Publicado no Int J Radiat Oncol Biol Phys (2015)

The Personal Patient Profile-Prostate, Decision Support for Men With Localized Prostate Cancer: A Multi-center Randomized Trial

Por Berry, Donna L, Halpenny, Barbara, Hong, Fangxin, Wolpin, Seth, Lober, William B, Russell, Kenneth J, Ellis, William J, Govindarajulu, Usha, Bosco, Jaclyn, Davison, B Joyce, Bennett, Gerald, Terris, Martha K, Barsevick, Andrea, Lin, Daniel W, Yang, Claire C, Swanson, Greg
Publicado em 2011